Heart Test Correlations

HSCSW Stock  USD 0.05  0.03  35.75%   
The current 90-days correlation between Heart Test Laboratories and Bone Biologics Corp is -0.07 (i.e., Good diversification). The correlation of Heart Test is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.

Heart Test Correlation With Market

Significant diversification

The correlation between Heart Test Laboratories and DJI is 0.05 (i.e., Significant diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Heart Test Laboratories and DJI in the same portfolio, assuming nothing else is changed.
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Heart Test Laboratories. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.

Related Correlations Analysis


Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

DHAIVERO
BJDXSHPH
DHAIBBLG
VEROBBLG
GCTKVERO
DHAISHPH
  

High negative correlations

MOVEBBLG
MOVESHPH
MOVEDHAI
MOVEVERO
MOVEVTAK
GCTKMOVE

Risk-Adjusted Indicators

There is a big difference between Heart Stock performing well and Heart Test Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Heart Test's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
BBLG  3.78 (0.88) 0.00 (0.45) 0.00 
 6.84 
 22.82 
VERO  4.01 (0.48) 0.00 (0.40) 0.00 
 8.14 
 54.80 
NAOV  5.98 (0.09) 0.00  0.61  0.00 
 10.43 
 93.37 
SHPH  5.45 (1.17) 0.00 (2.95) 0.00 
 9.90 
 35.78 
DHAI  65.28  26.89  0.70  0.99  25.85 
 193.55 
 900.00 
VTAK  4.67 (0.28) 0.00 (0.05) 0.00 
 13.33 
 35.41 
MOVE  7.65  1.59  0.19 (1.54) 6.42 
 10.98 
 164.71 
BJDX  6.19 (0.91) 0.00 (0.37) 0.00 
 10.19 
 87.65 
GCTK  4.43 (0.80) 0.00 (0.20) 0.00 
 11.45 
 34.35 
NDRA  5.77 (0.17) 0.00 (0.02) 0.00 
 13.24 
 49.07 

Heart Test Corporate Executives

Elected by the shareholders, the Heart Test's board of directors comprises two types of representatives: Heart Test inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Heart. The board's role is to monitor Heart Test's management team and ensure that shareholders' interests are well served. Heart Test's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Heart Test's outside directors are responsible for providing unbiased perspectives on the board's policies.
Mark HilzSecretary COOProfile